Hostname: page-component-cb9f654ff-mnl9s Total loading time: 0 Render date: 2025-08-04T01:22:11.619Z Has data issue: false hasContentIssue false

Reversible Metronidazole-Induced Encephalopathy after Prolonged Exposure to Metronidazole for Treatment of Pyogenic Spondylitis

Published online by Cambridge University Press:  21 May 2025

Jia-Qi Chen*
Affiliation:
Department of Neurology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China
*
Corresponding author: Jia-Qi Chen; Email: qjc600@163.com

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Neuroimaging Highlight
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Roy, U, Panwar, A, Pandit, A, Das, SK, Joshi, B. Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature. J Clin Diagn Res. 2016;10:19. DOI: 10.7860/JCDR/2016/19032.Google Scholar
Hobbs, K, Stern-Nezer, S, Buckwalter, MS, Fischbein, N, Finley Caulfield, A. Metronidazole-induced encephalopathy: not always a reversible situation. Neurocrit Care. 2015;22:429436. DOI: 10.1007/s12028-014-0102-9.Google Scholar
Sørensen, CG, Karlsson, WK, Amin, FM, Lindelof, M. Metronidazole-induced encephalopathy: a systematic review. J Neurol. 2020;267:113. DOI: 10.1007/s00415-018-9147-6.Google Scholar